Why Low Platelet Count Isn’t Lone Benchmark For Dengue Severity

New Delhi : The spurt in dengue cases in Delhi and neighbouring areas over the past few weeks has led to a heavy rush in hospitals.

It has also led to a rise in the demand for platelets, one of the cellular components along with white and red blood cells that play an important role in clotting and bleeding.

The normal platelet count ranges between 1.5 and 4 lakh per microlitre. In dengue fever, doctors say, there is increased destruction of platelets and reduction in the formation of new ones, which leads to low platelet count.

While transfusion in patients with very low platelet count and internal bleeding or rashes was important, preventive transfusion should be avoided, said doctors.

“One of the main reasons for people seeking admission to hospitals in dengue cases is low platelet count. They insist on it, even when there are no other warning signs,” said Dr Rajesh Chawla, senior consultant, pulmonary and critical care at Apollo Hospital.

A report published by AIIMS in Open Forum Infectious Diseases in 2016 found 10% of patients had bleeding manifestation, which was deadly, even when their platelet counts were normal. In contrast, 15 patients had no bleeding even with less than 10,000/mm3 platelet count, which was considered very low.

The study was based on an analysis of clinical and laboratory characteristics of 369 dengue patients admitted to AIIMS between August and November 2015.

“Transfusion runs the risk of transmitted infections,” said Dr Jyoti Kotwal, chairperson, department of haematology, Sir Ganga Ram Hospital. “Platelet transfusion should not be overprescribed. In our hospital, we conduct immature platelet fraction tests before deciding whether a patient needs transfusion or not. It measures young platelet count instead of absolute count, which is a more reliable indicator of severity,” she added.

According to Dr Rommel Tickoo, director, internal medicine at Max Saket, pain in the abdomen, less than 20,000 platelet count, respiratory distress and internal bleeding or rashes were true warning signs that necessitated urgent medical attention and intervention.

“A majority of patients will recover with supportive therapy. Maintaining hydration is the most crucial factor. Also, patients should not delay getting the test done. We see patients who keep waiting at home with high fever for 5-6 days and rush to hospital with severe symptoms. One should get the dengue test done if fever and other symptoms persist for two days or more for timely diagnosis and treatment,” added Tickoo.

  • Related Posts

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Releasing One- Year DEXA analysis, Aakash Healthcare red flags stressing Early Detection and Timely Intervention.  New Delhi: On the occasion of World Osteoporosis Day, Aakash Healthcare has released an analysis…

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    The Prodigy got appointed Pro- VC of a Health Science University when He was just 33 Three Years ago. Nagpur/ Wardha: Three PhDs in health!!! Such rare accomplishment is the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Low Bone Density in Nearly 7 in 10 Patients Pointing to High Risk of Osteoporosis

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Hat Trick of PhDs in Health: Three Cheers for the Rare Researcher

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

    Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

    Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

    Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27